Treatment of Chronic Active Antibody-Mediated Kidney Transplant Rejection With Intravenous Immunoglobulin

被引：0
|
作者：
Rapetskaya, Nadzeya [1 ]
Komissarov, Kirill [2 ]
Kalachyk, Aleh [2 ]
机构：
[1] State Inst Minsk Sci & Pract Ctr Surg Transplanto, Transplant Nephrol, Minsk, BELARUS
[2] State Inst Minsk Sci & Pract Ctr Surg Transplanto, Nephrol, Renal Replacement Trerapy & Kidney Transplantat, Minsk, BELARUS
来源：
TRANSPLANTATION | 2022年 / 106卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P8.049
引用
收藏
页码：S572 / S572
页数：1
相关论文
共 50 条
  • [21] Impact of ABO incompatibility and early antibody-mediated rejection on chronic antibody-mediated rejection in kidney transplant patients
    Ga Young Heo
    Yunyoung Jang
    Hyungwook Choi
    Yong Chul Kim
    Seung Seok Han
    Hyung Woo Kim
    Juhan Lee
    Kyu Ha Huh
    Beom Seok Kim
    Jaeseok Yang
    Journal of Nephrology, 2023, 36 : 2571 - 2580
  • [22] Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin
    Ban, Tae Hyun
    Lee, Sua
    Kim, Hyung Duk
    Ko, Eun Jeong
    Kim, Bo-Mi
    Kim, Kyoung-Woon
    Chung, Byung Ha
    Yang, Chul Woo
    STEM CELLS INTERNATIONAL, 2021, 2021
  • [23] Use of Intravenous Immunoglobulin and Rituximab for the prevention and treatment of antibody-mediated rejection
    Jordan, S.
    XENOTRANSPLANTATION, 2009, 16 (05) : 330 - 331
  • [24] Daratumumab for Treatment of Antibody-Mediated Rejection in a Kidney Transplant Recipient
    Jordan, S. C.
    Vescio, R.
    Toyoda, M.
    Ammerman, N.
    Huang, E.
    Peng, A.
    Sethi, S.
    Najjar, R.
    Lim, K.
    Vo, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1062 - 1062
  • [25] Acute Antibody-Mediated Rejection of the Kidney Transplant
    Sladoje-Martinovic, B.
    Orlic, L.
    Zivcic-Cosic, S.
    Racki, S.
    Vuksanovic-Mikulicic, S.
    Maleta, I
    Bubic, I
    Pavletic-Persic, M.
    TRANSPLANTATION, 2012, 94 (10) : 1036 - 1036
  • [26] Prevention of antibody-mediated kidney transplant rejection
    Morath, Christian
    Opelz, Gerhard
    Zeier, Martin
    Suesal, Caner
    TRANSPLANT INTERNATIONAL, 2012, 25 (06) : 633 - 645
  • [27] Tocilizumab in Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: A Case Series.
    Boonpheng, B.
    Bakthavatsalam, R.
    Blosser, C. D.
    De Castro, I. C.
    Gimferrer, I.
    Ng, Y.
    Leca, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 959 - 959
  • [28] EFFECTIVE STRATEGY FOR CHRONIC ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS
    Park, Woo Yeong
    Park, Ha Yeon
    Yeo, Sang Mok
    Kang, Seong Sik
    Park, Sung Bae
    Jin, Kyubok
    Han, Seungyeup
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [29] Plasma Exchange and Intravenous Immunoglobulin in Treatment of Antibody-Mediated Rejection after Kidney Transplantation: Slovenian Experience
    Gubensek, J.
    Ponikvar, Buturovic J.
    Kandus, A.
    Arnol, M.
    Kovac, J.
    Marn-Pernat, A.
    Lindic, J.
    Kovac, D.
    Ponikvar, R.
    TRANSPLANTATION, 2012, 94 (10) : 1026 - 1026
  • [30] Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation
    Muller, Yannick D.
    Ghaleb, Nseir
    Rotman, Samuel
    Vionnet, Julien
    Halfon, Matthieu
    Catana, Emmanuelle
    Golshayan, Dela
    Venetz, Jean-Pierre
    Aubert, Vincent
    Pascual, Manuel
    TRANSPLANT INTERNATIONAL, 2018, 31 (04) : 451 - 455
12345